Relation expands its GSK partnership for up to $110M, tapping new AI model MORGAN to sharpen drug discovery and biology insights.
David Roblin, Relation CEO
July 30, 2026 07:12 AM EDT
Relation promises 'transformationally different success rates' in expanded AI pact with GSK
Elizabeth Cairns
Senior biopharma journalist
Relation unveiled MORGAN, an AI “foundation model of the cell,” plus a GSK deal worth up to $110m to make the data to train it.
Cette initiative en matière d'IA vise à accélérer le développement de médicaments à un stade très précoce. Elle pourrait…
GSK has said agentic AI is already affecting every asset in its pipeline, as pharmaceutical companies race to use the technology
ABB Roche’s launch global partnership to develop new robotic solutions for clinical laboratories.
The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have…
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
Reckitt Forges Historic Seven-Partner Alliance to Deliver Better Health in More Hands, Every Day
